Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
RECOMBINANT HVT AND USES THEREOF
Document Type and Number:
WIPO Patent Application WO/2022/079160
Kind Code:
A3
Abstract:
The present invention relates to recombinant herpes viruses comprising recombinant nucleotide sequences encoding at least two different antigens. The invention is particularly suited for producing vaccines to immunize avian species against avian pathogen(s).

Inventors:
ESAKI MOTOYUKI (JP)
PALYA VILMOS (HU)
TATAR TIMEA (HU)
PENZES ZOLTAN (HU)
Application Number:
PCT/EP2021/078432
Publication Date:
May 27, 2022
Filing Date:
October 14, 2021
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
CEVA SANTE ANIMALE (FR)
International Classes:
A61K39/12; A61P31/14; A61P31/16
Domestic Patent References:
WO2015032909A12015-03-12
Foreign References:
EP2644702A12013-10-02
Other References:
CARNACCINI SILVIA ET AL: "H9 Influenza Viruses: An Emerging Challenge", COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, vol. 10, no. 6, 23 December 2019 (2019-12-23), pages a038588, XP055793756, DOI: 10.1101/cshperspect.a038588
LIU D ET AL: "Poultry carrying H9N2 act as incubators for novel human avian infl uenza viruses", THE LANCET, 8 March 2014 (2014-03-08), pages 869 - 869, XP055793768, DOI: 10.1016/s0140
ANONYMOUS: "UPI000188F43D - Influenza A virus (A/avian/Israel/313/2008(H9N2))", 25 December 2008 (2008-12-25), XP055794048, Retrieved from the Internet [retrieved on 20210408]
Attorney, Agent or Firm:
CABINET BECKER ET ASSOCIES (FR)
Download PDF: